Vascular cell adhesion molecule-1 (VCAM-1) blockade in collagen-induced arthritis reduces joint involvement and alters B cell trafficking.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMC 1906373)

Published in Clin Exp Immunol on April 01, 2002

Authors

R A Carter1, I K Campbell, K L O'Donnel, I P Wicks

Author Affiliations

1: Reid Rheumatology Laboratory, Autoimmunity and Transplantation Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.

Articles citing this

Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol (2010) 2.12

The chemokine receptor CXCR2 ligand KC (CXCL1) mediates neutrophil recruitment and is critical for development of experimental Lyme arthritis and carditis. Infect Immun (2010) 1.19

Endothelial cell phenotypes in the rheumatoid synovium: activated, angiogenic, apoptotic and leaky. Arthritis Res Ther (2004) 1.07

VCAM-1 and VLA-4 modulate dendritic cell IL-12p40 production in experimental visceral leishmaniasis. PLoS Pathog (2008) 0.94

6-Shogaol reduced chronic inflammatory response in the knees of rats treated with complete Freund's adjuvant. BMC Pharmacol (2006) 0.90

Largazole, a class I histone deacetylase inhibitor, enhances TNF-α-induced ICAM-1 and VCAM-1 expression in rheumatoid arthritis synovial fibroblasts. Toxicol Appl Pharmacol (2013) 0.90

Site-specific targeting of antibody activity in vivo mediated by disease-associated proteases. J Control Release (2012) 0.85

Photoaffinity labeling in target- and binding-site identification. Future Med Chem (2015) 0.84

The CO donor CORM-2 inhibits LPS-induced vascular cell adhesion molecule-1 expression and leukocyte adhesion in human rheumatoid synovial fibroblasts. Br J Pharmacol (2014) 0.76

Amelioration of lacrimal gland inflammation by oral administration of K-13182 in Sjögren's syndrome model mice. Clin Exp Immunol (2007) 0.76

Simple modifications to methimazole that enhance its inhibitory effect on tumor necrosis factor-α-induced vascular cell adhesion molecule-1 expression by human endothelial cells. Eur J Pharmacol (2015) 0.75

Ig-like domain 6 of VCAM-1 is a potential therapeutic target in TNFα-induced angiogenesis. Exp Mol Med (2017) 0.75

Articles cited by this

Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell (1991) 13.70

Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell (1989) 9.06

VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell (1990) 8.87

Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J Exp Med (2001) 5.97

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci U S A (1992) 5.07

An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science (1989) 4.01

Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood (1990) 3.65

Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol (1996) 3.59

Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor alpha 4 beta 1. Cell (1990) 3.46

Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science (1993) 3.30

Hematopoietic progenitor cell rolling in bone marrow microvessels: parallel contributions by endothelial selectins and vascular cell adhesion molecule 1. J Exp Med (1998) 3.26

A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture. J Cell Biol (1991) 3.23

Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice. Development (1995) 3.19

Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature (1995) 3.07

Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J Immunol (1988) 2.80

Targeted disruption of the murine VCAM1 gene: essential role of VCAM-1 in chorioallantoic fusion and placentation. Genes Dev (1995) 2.61

Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues. Lab Invest (1991) 2.59

Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis. Eur J Immunol (2000) 2.33

Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. J Immunol (1998) 2.30

Adhesion through the LFA-1 (CD11a/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells. J Immunol (1994) 2.11

Alpha 4/beta 1 integrin (VLA-4) ligands in arthritis. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. J Immunol (1992) 2.08

Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci. J Exp Med (1985) 2.01

Adhesion molecules: a rheumatologic perspective. Arthritis Rheum (1997) 1.80

The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J Leukoc Biol (2000) 1.66

Adhesion of human B cells to follicular dendritic cells involves both the lymphocyte function-associated antigen 1/intercellular adhesion molecule 1 and very late antigen 4/vascular cell adhesion molecule 1 pathways. J Exp Med (1991) 1.64

Differential distribution of intercellular adhesion molecules (ICAM-1, ICAM-2, and ICAM-3) and the MS-1 antigen in normal and diseased human synovia. Their possible pathogenetic and clinical significance in rheumatoid arthritis. Arthritis Rheum (1994) 1.64

The VLA-4/VCAM-1 pathway is involved in lymphocyte adhesion to endothelium in rheumatoid synovium. J Immunol (1991) 1.63

Neonatally induced inactivation of the vascular cell adhesion molecule 1 gene impairs B cell localization and T cell-dependent humoral immune response. J Exp Med (2001) 1.62

Distinct roles for the NF-kappaB1 (p50) and c-Rel transcription factors in inflammatory arthritis. J Clin Invest (2000) 1.62

Expression of vascular cell adhesion molecule-1 in normal and inflamed synovium. Lab Invest (1993) 1.50

Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum (1994) 1.41

Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2. Eur J Immunol (1996) 1.31

Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1- and CD106 (VCAM-1)-dependent mechanism. J Clin Invest (2001) 1.30

Vascular cell adhesion molecule 1 (CD106): a multifaceted regulator of joint inflammation. Arthritis Rheum (2001) 1.16

A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis. Br J Rheumatol (1997) 1.13

Rheumatoid arthritis synovial stromal cells inhibit apoptosis and up-regulate Bcl-xL expression by B cells in a CD49/CD29-CD106-dependent mechanism. J Immunol (2000) 1.05

Soluble VCAM-1 induces chemotaxis of Jurkat and synovial fluid T cells bearing high affinity very late antigen-4. J Immunol (1998) 1.03

Identification of a new non-major histocompatibility complex genetic locus on chromosome 2 that controls disease severity in collagen-induced arthritis in rats. Arthritis Rheum (1998) 1.01

Molecular and cellular mediators of interleukin-1-dependent acute inflammatory arthritis. Arthritis Rheum (2001) 1.00

Alternatively spliced CS-1 fibronectin isoform and its receptor VLA-4 in rheumatoid arthritis synovium. J Rheumatol (1997) 0.99

Soluble vascular cell adhesion molecule 1 mediation of monocyte chemotaxis in rheumatoid arthritis. Arthritis Rheum (2000) 0.96

Integrins and other adhesion molecules on lymphocytes from synovial fluid and peripheral blood of rheumatoid arthritis patients. Eur J Immunol (1992) 0.95

Induction of persistent T cell hyporesponsiveness in vivo by monoclonal antibody to ICAM-1 in patients with rheumatoid arthritis. J Immunol (1995) 0.95

The effect of anti-adhesion molecule antibody on the development of collagen-induced arthritis. Cell Immunol (1992) 0.95

Direct interaction with primed CD4+ CD45R0+ memory T lymphocytes induces expression of endothelial leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1 on the surface of vascular endothelial cells. Eur J Immunol (1991) 0.94

Germinal center reaction in the joints of mice with collagen-induced arthritis: an animal model of lymphocyte activation and differentiation in arthritis joints. Arthritis Rheum (2001) 0.93

Regulation of synovial B cell survival in rheumatoid arthritis by vascular cell adhesion molecule 1 (CD106) expressed on fibroblast-like synoviocytes. Arthritis Rheum (2000) 0.88

Immunohistological and functional analysis of adhesion molecule expression in the rheumatoid synovial lining layer. Implications for synovial lining cell destruction. J Rheumatol (1994) 0.85

Alpha 4 integrin-dependent leukocyte recruitment does not require VCAM-1 in a chronic model of inflammation. J Immunol (2000) 0.85

Vascular cell adhesion molecule 1 (CD106) on primary human articular chondrocytes: functional regulation of expression by cytokines and comparison with intercellular adhesion molecule 1 (CD54) and very late activation antigen 2. Arthritis Rheum (1998) 0.85

Generation of dendritic cell-like antigen-presenting cells in long-term mixed leucocyte culture: phenotypic and functional studies. Immunology (1997) 0.79

Expression of vascular cell adhesion molecule-1 by follicular dendritic cells. Leuk Lymphoma (1995) 0.78

VCAM-1 influences lymphocyte proliferation and cytokine production during mixed lymphocyte responses. Cell Immunol (1994) 0.77

Articles by these authors

Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum (2002) 2.62

Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis. Eur J Immunol (2000) 2.33

Screening for atherosclerosis in patients with rheumatoid arthritis: comparison of two in vivo tests of vascular function. Arthritis Rheum (2003) 1.78

The role of the LFA-1/ICAM-1 interaction in human leukocyte homing and adhesion. Immunol Rev (1989) 1.75

Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritis Res (2001) 1.66

Distinct roles for the NF-kappaB1 (p50) and c-Rel transcription factors in inflammatory arthritis. J Clin Invest (2000) 1.62

Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation. J Exp Med (2001) 1.55

Severe inflammatory arthritis and lymphadenopathy in the absence of TNF. J Clin Invest (2001) 1.40

Audio-visual recording in the surgery: do patients mind? J R Coll Gen Pract (1982) 1.34

Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis. Ann Rheum Dis (2004) 1.20

Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway. Am J Pathol (1999) 1.19

Vascular cell adhesion molecule 1 (CD106): a multifaceted regulator of joint inflammation. Arthritis Rheum (2001) 1.16

Human articular cartilage secretes characteristic metal dependent proteinases upon stimulation by mononuclear cell factor. J Rheumatol (1986) 1.05

Isolation and characterization of a novel receptor-type protein tyrosine kinase (hek) from a human pre-B cell line. J Biol Chem (1992) 1.05

Exacerbation of acute inflammatory arthritis by the colony-stimulating factors CSF-1 and granulocyte macrophage (GM)-CSF: evidence of macrophage infiltration and local proliferation. Clin Exp Immunol (2000) 1.02

The action of human articular-cartilage metalloproteinase on proteoglycan and link protein. Similarities between products of degradation in situ and in vitro. Biochem J (1986) 1.01

Molecular and cellular mediators of interleukin-1-dependent acute inflammatory arthritis. Arthritis Rheum (2001) 1.00

Generation and novel distribution of matrix metalloproteinase-derived aggrecan fragments in porcine cartilage explants. J Biol Chem (2000) 0.99

Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis. Rheumatology (Oxford) (2005) 0.95

Plasminogen activators and their inhibitors in arthritic disease. Ann N Y Acad Sci (1992) 0.93

Targeted insertion of a lacZ reporter gene into the mouse Cer1 locus reveals complex and dynamic expression during embryogenesis. Genesis (2000) 0.90

Outcome of rheumatoid arthritis and psoriasis following autologous stem cell transplantation for hematologic malignancy. Arthritis Rheum (1997) 0.88

Isolation and characterization of the promoter region of the human intercellular adhesion molecule-1 gene. Int Immunol (1991) 0.82

Chondrosarcoma of the calcaneum and massive soft tissue calcification in a patient with hereditary and acquired connective tissue diseases. Ann Rheum Dis (1987) 0.82

Regulation of plasminogen activator activity in arthritic joints. J Rheumatol Suppl (1991) 0.81

Characterization of latent and active forms of cartilage proteinases produced by normal immature rabbit articular cartilage in tissue culture. Arthritis Rheum (1983) 0.80

TNFalpha and response of treatment-resistant adult-onset Still's disease to thalidomide. Lancet (1998) 0.80

The role of accessory molecules in lymphocyte activation. Transplant Proc (1989) 0.80

Characterization of a human synovial cell antigen: VCAM-1 and inflammatory arthritis. Immunol Cell Biol (2001) 0.80

Otological and vestibular symptoms in patients with low grade (Quebec grades one and two) whiplash injury. J Laryngol Otol (2008) 0.78

Will sialylation change intravenous immunoglobulin therapy in the future? Clin Exp Immunol (2014) 0.76

Arterial stiffness is increased in systemic sclerosis: a cross-sectional comparison with matched controls. Clin Exp Rheumatol (2014) 0.76

Aortic incompetence associated with severe rheumatoid arthritis. Med J Aust (1987) 0.76

Audit. Br J Gen Pract (1997) 0.75

Calcium and magnesium ions: influence on the response of an isolated artery to sympathetic nerve stimulation, noradrenaline and tyramine. Br J Pharmacol Chemother (1967) 0.75

The primary prevention of atherosclerosis in general practice. J R Coll Gen Pract (1978) 0.75

Treatment of post-herpetic neuralgia. BMJ (1989) 0.75

The role of mononuclear cell products as modulators of cartilage degradation. J Rheumatol (1987) 0.75

Mononuclear cell factor modulates the concomitant release of proteoglycan and latent proteinase by human articular cartilage in organ culture. Agents Actions Suppl (1986) 0.75

Prolonged prodrome, systemic vasculitis, and deafness in Cogan's syndrome. Ann Rheum Dis (2001) 0.75

Gross abdominal lymphadenopathy in sarcoidosis. Intern Med J (2002) 0.75

Visual loss as the presenting feature of giant cell arteritis. Aust N Z J Med (2000) 0.75

Medical records. III-Improving records in a group practice. Br Med J (Clin Res Ed) (1981) 0.75

Prolonged response of multicentric reticulohistiocytosis to low dose methotrexate. J Rheumatol (1998) 0.75

The response of an isolated artery to sympathomimetic amines. J Pharm Pharmacol (1968) 0.75

An unusual cause of back pain. Aust Fam Physician (1999) 0.75